Table 2.
Sex | Age | Shoulder involved | Preoperative | Postoperative | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Constant | Patte’s score | Thomazeau’s score | VAS | Constant* | Patte’s Score | Thomazeau’s Score | VAS | Recurrent tear | Repair Integrity | AEs | ||||||
Contralateral shoulder | Injured shoulder | Contralateral shoulder | Injured shoulder | |||||||||||||
Control group | ||||||||||||||||
HCSC-1 | Male | 65 | LS | 93 | 60 | 1 | 1 | 8 | 91 | 33.5 | 1 | 1 | 1 | Yes | No | No |
HCSC-2 | Mujer | 66 | RS | 96 | 56 | 1 | 1 | 8 | 92 | 71 | 2 | 2 | 2 | Yes | No | Yes |
HCSC-13 | Male | 62 | RS | 75 | 48 | 1 | 1 | 9 | 70 | 66 | 2 | 2 | 4 | Yes | No | No |
HCSC-14 | Female | 57 | RS | 81 | 55 | 1 | 1 | 8 | 84 | 80 | 1 | 1 | 2 | No | Yes | No |
HCSC-15 | Female | 59 | RS | 80 | 37 | 2 | 2 | 8 | 80 | 77 | 1 | 1 | 2 | No | Yes | No |
Treatment group | ||||||||||||||||
HCSC-3 | Male | 61 | RS | 65 | 30 | 3 | 3 | 9 | 87 | 63 | 3 | 3 | 6 | Yes | No | No |
HCSC-4 | Male | 62 | RS | 79 | 36 | 2 | 2 | 9 | 79 | 43 | 3 | 3 | 8 | Yes | No | Yes |
HCSC-5 | Male | 48 | RS | 94 | 35 | 2 | 2 | 8 | 96 | 62 | 3 | 3 | 3 | Yes | No | Yes |
HCSC-6 | Male | 60 | RS | 91 | 53 | 2 | 1 | 8 | 91 | 86 | 2 | 2 | 1 | Yes | No | No |
HCSC-7 | Male | 49 | RS | 89 | 63 | 1 | 1 | 7 | 98 | 87 | 2 | 2 | 1 | No | Yes | No |
HCSC-10 | Female | 60 | RS | 87 | 48 | 1 | 1 | 8 | 93 | 74 | 2 | 2 | 2 | Yes | No | Yes |
HCSC-11 | Male | 49 | RS | 89 | 48 | 1 | 1 | 8 | 90 | 79 | 1 | 1 | 1 | No | Yes | No |
HCSC-12 | Female | 65 | RS | 80 | 43 | 1 | 1 | 8 | 80 | 82 | 1 | 1 | 1 | No | Yes | No |
AEs adverse events, VAS visual analogue scale
* Statistically significant recovery between injured and contralateral shoulder in the treatment group. P = 0.0073